The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

Metabolic Guidelines Article

Article on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Read More

Dementia Guidelines Meeting

Clinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

New world order: Brexit, drugs and research

Letter to House of Commons Science and Technology Committee
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Ketamine Scheduling

BAP endorses the Fact Sheet on Ketamine Scheduling
Read More

Psychoactive Substances Bill

The BAP response to the proposed bill
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event BAP Session BAP Event BAP Stand

All Events

4th November 2016 Translational Neuroscience and Mental Disorders Ettore Majorana Foundation and Centre for Scientific Culture, Via Guarnotta, 26, ITALY
15th November 2016 Perinatal and Infant Mental Health: Intrinsic Links and Integrated Strategies Conference Pen Green Conference Centre, Corby
17th November 2016 Child and Adolescent Psychopharmacology Vista Suite, Park Plaza Hotel, Maid Marian Way, Nottingham

Clinical Certificate | Masterclasses | Non-Clinical Certificate


Andrew Mayers
It's okay to talk this world suicide prevention day
Andrew talks to Dorset Eye about how suicide affects everybody
7th September 2016

Will Lawn et al
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses
Will Lawn and colleagues have published a paper about cannabis and motivation, covered in The Times and Independent newspapers.
2nd September 2016

Stephen Lawrie
Mental Health is...Mental
Stephen was at the Edinburgh Fringe arguing that words like Mental and phrases like Mental Health are best avoided, and that talking about the Stigma of Mental Health/Illness is itself stigmatising.
4th August 2016

See more media


Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
12th September 2016

The Fundamentals of Clinical Psychopharmacology has won the BMA Medical Book Award in Psychiatry
Read more
New world order: Brexit, drugs and research
12th August 2016

Oliver Howes wrote to House of Commons Science and Technology Committee to raise issues on behalf of the BAP following the Brexit vote.
Read BAP letter to Nicola Blackwood
NIHR Research funding opportunity
27th July 2016

NIHR research funding opportunities for the Health Technology Assessment (HTA) programme
View funding opportunties
Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology
13th April 2016

Journal of Psychopharmacology chosen to trial new Neuroscience-based Nomenclature (NbN).
Read more

See more news